Facebook Twitter Tumblr Close Skip to main content
A Project of The Annenberg Public Policy Center

FDA Did Not Change Position on Ivermectin Use, Contrary to Online Claims

FDA Did Not Change Position on Ivermectin Use, Contrary to Online Claims

In response to a civil suit, lawyers for the Food and Drug Administration described the agency’s warnings about the unapproved use of ivermectin to treat COVID-19 as “recommendations.” Although that description doesn’t reveal new information, some conservative outlets have falsely claimed it’s an “outrageous” revelation and a change in the FDA’s position.